| Product NDC: | 0005-2500 |
| Proprietary Name: | FIBERCON |
| Non Proprietary Name: | CALCIUM POLYCARBOPHIL |
| Active Ingredient(s): | 625 mg/1 & nbsp; CALCIUM POLYCARBOPHIL |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0005-2500 |
| Labeler Name: | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part334 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20040105 |
| Package NDC: | 0005-2500-23 |
| Package Description: | 140 TABLET in 1 BOTTLE (0005-2500-23) |
| NDC Code | 0005-2500-23 |
| Proprietary Name | FIBERCON |
| Package Description | 140 TABLET in 1 BOTTLE (0005-2500-23) |
| Product NDC | 0005-2500 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | CALCIUM POLYCARBOPHIL |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20040105 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
| Substance Name | CALCIUM POLYCARBOPHIL |
| Strength Number | 625 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |